| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RAPID COMMUNICATION |
Department of Internal Medicine (C.T., P.Q.L.), Childrens Unit, Centre Hospitalier Etterbeek-Ixelles, B-1050 Brussels; Institut für Biochemie (S.W.S., S.H., M.W.), Universität Erlangen-Nürnberg, D-91054 Germany; and 3Department of Medical Genetics (J.P., M.J.A.), Hôpital Erasme and Laboratory of Medical Genetics, Université Libre de Bruxelles, B-1070 Brussels, Belgium
Address all correspondence and requests for reprints to: Marc J. Abramowicz, M.D., Ph.D., Genetics Department, Hôpital Erasme, Univerxité Libre de Bruxelles, 808 Route de Lennik, 1070 Brussels, Belgium. E-mail: marcabra{at}ulb.ac.be.
Abstract
Isolated hypoparathyroidism is an uncommon metabolic disorder characterized by hypocalcemia and hyperphosphatemia, with absent or low levels of PTH. It may present as an apparently sporadic disorder or may be transmitted in families as a genetic trait. Mutations of the calcium-sensing receptor gene and of the preproPTH gene have been reported in occasional cases, and a mutation of the parathyroid-specific transcription factor GCMB gene has been reported in one familial case. We report a second family with isolated hypoparathyroidism and a GCMB mutation. The patients were two siblings from asymptomatic, first-cousin parents, indicating autosomal recessive inheritance. The mutation consisted of the substitution of a glycine residue with a serine at position 63 (G63S) in the DNA-binding GCM domain of GCMB. Functional studies in transfected cells showed that the mutation caused loss of GCMB function, as it abolished transactivation capacity, despite normal subcellular localization, protein stability, and DNA-binding specificity. Contrary to the previously reported family, our patients displayed low but clearly detectable levels of PTH in plasma. This residual hormone secretion probably results from a very small residual activity of the G63S mutant GCMB.
This article has been cited by other articles:
![]() |
M. Mannstadt, G. Bertrand, M. Muresan, G. Weryha, B. Leheup, S. R. Pulusani, B. Grandchamp, H. Juppner, and C. Silve Dominant-Negative GCMB Mutations Cause an Autosomal Dominant Form of Hypoparathyroidism J. Clin. Endocrinol. Metab., September 1, 2008; 93(9): 3568 - 3576. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Shoback Hypoparathyroidism N. Engl. J. Med., July 24, 2008; 359(4): 391 - 403. [Full Text] [PDF] |
||||
![]() |
A. Maret, C. Ding, S. L. Kornfield, and M. A. Levine Analysis of the GCM2 Gene in Isolated Hypoparathyroidism: A Molecular and Biochemical Study J. Clin. Endocrinol. Metab., April 1, 2008; 93(4): 1426 - 1432. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Suva PTH Expression, Not Always where You Think ... J. Clin. Endocrinol. Metab., February 1, 2006; 91(2): 396 - 397. [Full Text] [PDF] |
||||
![]() |
J. N. VanHouten, N. Yu, D. Rimm, J. Dotto, A. Arnold, J. J. Wysolmerski, and R. Udelsman Hypercalcemia of Malignancy due to Ectopic Transactivation of the Parathyroid Hormone Gene J. Clin. Endocrinol. Metab., February 1, 2006; 91(2): 580 - 583. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |